TAF1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.797000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.421400E-01
Normal-vs-Stage2
7.707400E-01
Normal-vs-Stage3
4.718800E-01
Normal-vs-Stage4
4.705400E-01
Stage1-vs-Stage2
7.717000E-01
Stage1-vs-Stage3
1.516590E-01
Stage1-vs-Stage4
2.638800E-01
Stage2-vs-Stage3
1.420240E-01
Stage2-vs-Stage4
1.961960E-01
Stage3-vs-Stage4
9.909600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.849600E-01
Normal-vs-AfricanAmerican
4.245000E-01
Normal-vs-Asian
6.828800E-01
Caucasian-vs-AfricanAmerican
2.209200E-01
Caucasian-vs-Asian
2.700800E-01
AfricanAmerican-vs-Asian
5.173600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.135800E-01
Normal-vs-Female
9.720800E-01
Male-vs-Female
3.885200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.932000E-01
Normal-vs-Age(41-60Yrs)
7.696000E-01
Normal-vs-Age(61-80Yrs)
9.202600E-01
Normal-vs-Age(81-100Yrs)
9.832200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.846200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.447400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.130000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.300200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.045400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.354400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.914200E-01
Normal-vs-Daily Drinker
8.844800E-01
Normal-vs-Weekly Drinker
9.630000E-01
Normal-vs-Occasional Drinker
6.212400E-01
Normal-vs-Social Drinker
8.656600E-01
Non Drinker-vs-Daily Drinker
5.236800E-01
Non Drinker-vs-Weekly Drinker
7.213200E-01
Non Drinker-vs-Occasional Drinker
3.922600E-01
Non Drinker-vs-Social Drinker
8.957200E-01
Daily Drinker-vs-Weekly Drinker
8.600000E-01
Daily Drinker-vs-Occasional Drinker
1.997010E-01
Daily Drinker-vs-Social Drinker
5.404400E-01
Weekly Drinker-vs-Occasional Drinker
3.329400E-01
Weekly Drinker-vs-Social Drinker
7.004600E-01
Occasional Drinker-vs-Social Drinker
5.722600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.756000E-01
Normal-vs-Grade 2
4.292000E-02
Normal-vs-Grade 3
6.326400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.278320E-02
Grade 1-vs-Grade 3
6.343500E-03
Grade 1-vs-Grade 4
1.756000E-01
Grade 2-vs-Grade 3
2.702200E-01
Grade 2-vs-Grade 4
4.292000E-02
Grade 3-vs-Grade 4
6.326400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.770400E-01
Normal-vs-NonDiabetic
9.420000E-01
Diabetic-vs-NonDiabetic
4.454800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.141200E-01
Normal-vs-NoPancreatitis
9.391400E-01
Pancreatitis-vs-NoPancreatitis
5.483600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.791800E-01
Normal-vs-N1
8.323600E-01
N0-vs-N1
8.355800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.586200E-01
Normal-vs-TP53-NonMutant
8.793200E-01
TP53-Mutant-vs-TP53-NonMutant
2.239700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
